Cafestol-derivatives as potential FXR agonists and CYP7A1 inhibitors and their impact on hypercholesterolemia: an in silico study. [PDF]
da Silva MAE +5 more
europepmc +1 more source
A Review on Farnesoid X Receptor (FXR) Modulators Focusing on Benzimidazole Scaffold. [PDF]
Teno N, Gohda K, Fujimori K.
europepmc +1 more source
Bile acid signaling, metabolism, and aging. [PDF]
Sun J, Zhang S, Jin L, Huang W.
europepmc +1 more source
Pathogenesis and intervention strategies for metabolic dysfunction-associated fatty liver disease from the perspective of the gut-microbiota-liver axis. [PDF]
Liao J +12 more
europepmc +1 more source
Recent advances in gut microbiota metabolite regulation of hepatic pregnane X receptor. [PDF]
Lin T +5 more
europepmc +1 more source
Evolutionary remodeling of the FXR binding pocket drove functional divergence and ligand discrimination. [PDF]
Yamamoto N +7 more
europepmc +1 more source
Impact of Bile Acid Amidation on In Silico Farnesoid X Receptor Dynamics. [PDF]
Eisert-Sasse RK, Biswas A, Okafor CD.
europepmc +1 more source
Cholestasis in hepatitis E virus infection. [PDF]
Kanda T +6 more
europepmc +1 more source
The local-mechanical and systemic-metabolic dialogue: A new dawn in osteoarthritis treatment. [PDF]
Wang D +7 more
europepmc +1 more source
Synergistic therapeutic strategies for metabolic dysfunction-associated steatohepatitis and type 2 diabetes mellitus: molecular insights and clinical advances. [PDF]
Zhu B.
europepmc +1 more source

